Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Front Chem ; 6: 278, 2018.
Article in English | MEDLINE | ID: mdl-30050897

ABSTRACT

The Keggin-type polyoxometalate [γ-SiW10O36]8- was covalently modified to obtain a bis-biotinylated conjugate able to bind avidin. Spectroscopic studies such as UV-vis, fluorimetry, circular dichroism, coupled to surface plasmon resonance technique were used to highlight the unique interplay of supramolecular interactions between the homotetrameric protein and the bis-functionalized polyanion. In particular, the dual recognition mechanism of the avidin encompasses (i) a complementary electrostatic association between the anionic surface of the polyoxotungstate and each positively charged avidin subunit and (ii) specific host-guest interactions between each biotinylated arm and a corresponding pocket on the tetramer subunits. The assembly exhibits peroxidase-like reactivity and it was used in aqueous solution for L-methionine methyl ester oxidation by H2O2. The recognition phenomenon was then exploited for the preparation of layer-by-layer films, whose structural evolution was monitored in situ by ATR-FTIR spectroscopy. Finally, cell tracking studies were performed by exploiting the specific interactions with a labeled streptavidin.

4.
Bioconjug Chem ; 28(1): 161-170, 2017 01 18.
Article in English | MEDLINE | ID: mdl-28095682

ABSTRACT

Nanoparticle-based magnetic resonance imaging T2 negative agents are of great interest, and much effort is devoted to increasing cell-loading capability while maintaining low cytotoxicity. Herein, two classes of mixed-ligand protected magnetic-responsive, bimetallic gold/iron nanoparticles (Au/Fe NPs) synthesized by a two-step method are presented. Their structure, surface composition, and magnetic properties are characterized. The two classes of sulfonated Au/Fe NPs, with an average diameter of 4 nm, have an average atomic ratio of Au to Fe equal to 7 or 8, which enables the Au/Fe NPs to be superparamagnetic with a blocking temperature of 56 K and 96 K. Furthermore, preliminary cellular studies reveal that both Au/Fe NPs show very limited toxicity. MRI phantom experiments show that r2/r1 ratio of Au/Fe NPs is as high as 670, leading to a 66% reduction in T2 relaxation time. These nanoparticles provide great versatility and potential for nanoparticle-based diagnostics and therapeutic applications and as imaging contrast agents.


Subject(s)
Contrast Media/chemistry , Magnetic Resonance Imaging/methods , Metal Nanoparticles , Cell Division , Gold/chemistry , Iron/chemistry , Magnetics , Microscopy, Electron, Transmission , Powder Diffraction
5.
Bioconjug Chem ; 28(1): 43-52, 2017 01 18.
Article in English | MEDLINE | ID: mdl-28095690

ABSTRACT

Low intrinsic toxicity, high solubility, and stability are important and necessary features of gold nanoparticles to be used in the biomedical field. In this context, charged nanoparticles proved to be very versatile, and among them charged mixed-monolayer gold nanoparticles, displaying monolayers with well-defined morphologies, represent a paradigm. By using mixtures of hydrogenated and fluorinated thiols, the formation of monolayer domains may be brought to an extreme because of the immiscibility of fluorinated and hydrogenated chains. Following this rationale, mixed monolayer gold nanoparticles featuring ammonium, sulfonate, or carboxylic groups on their surface were prepared by using amphiphilic hydrogenated thiols and 1H,1H,2H,2H-perfluoro-alkanethiols. The toxicity of these systems was assessed in HeLa cells and was found to be, in general, low even for the cationic nanoparticles which usually show a high cytotoxicity and is comparable to that of homoligand gold nanoparticles displaying amphiphilic-charge neutral-hydrogenated or fluorinated thiolates in their monolayer. These properties make the mixed ligand monolayer gold nanoparticles an interesting new candidate for medical application.


Subject(s)
Gold/chemistry , Metal Nanoparticles/chemistry , Sulfhydryl Compounds/chemistry , Fluorescent Dyes/chemistry , Halogenation , HeLa Cells , Humans
6.
J Med Chem ; 57(12): 5333-47, 2014 Jun 26.
Article in English | MEDLINE | ID: mdl-24918261

ABSTRACT

In this account, we report the development of a series of substituted cinnamic anilides that represents a novel class of mitochondrial permeability transition pore (mPTP) inhibitors. Initial class expansion led to the establishment of the basic structural requirements for activity and to the identification of derivatives with inhibitory potency higher than that of the standard inhibitor cyclosporine-A (CsA). These compounds can inhibit mPTP opening in response to several stimuli including calcium overload, oxidative stress, and thiol cross-linkers. The activity of the cinnamic anilide mPTP inhibitors turned out to be additive with that of CsA, suggesting for these inhibitors a molecular target different from cyclophylin-D. In vitro and in vivo data are presented for (E)-3-(4-fluoro-3-hydroxy-phenyl)-N-naphthalen-1-yl-acrylamide 22, one of the most interesting compounds in this series, able to attenuate opening of the mPTP and limit reperfusion injury in a rabbit model of acute myocardial infarction.


Subject(s)
1-Naphthylamine/analogs & derivatives , Acrylamides/chemistry , Anilides/chemistry , Cinnamates/chemistry , Mitochondrial Membrane Transport Proteins/antagonists & inhibitors , Myocardial Reperfusion Injury/drug therapy , 1-Naphthylamine/chemical synthesis , 1-Naphthylamine/chemistry , 1-Naphthylamine/pharmacology , Acrylamides/chemical synthesis , Acrylamides/pharmacology , Anilides/chemical synthesis , Anilides/pharmacology , Animals , Calcium/metabolism , Cinnamates/chemical synthesis , Cinnamates/pharmacology , Female , Male , Mice, Inbred C57BL , Mitochondria, Heart/metabolism , Mitochondria, Liver/metabolism , Mitochondrial Membrane Transport Proteins/metabolism , Mitochondrial Permeability Transition Pore , Mitochondrial Swelling/drug effects , Myocardial Infarction/drug therapy , Myocardial Infarction/metabolism , Myocardial Reperfusion Injury/metabolism , Rabbits , Stereoisomerism , Structure-Activity Relationship
7.
Cancer Res ; 66(23): 11432-40, 2006 Dec 01.
Article in English | MEDLINE | ID: mdl-17145890

ABSTRACT

Tumor-associated macrophages (TAM) are a major inflammatory infiltrate in tumors and a major component of the protumor function of inflammation. TAM in established tumors generally have an M2 phenotype with defective production of interleukin-12 (IL-12) and high IL-10. Here, we report that defective responsiveness of TAM from a murine fibrosarcoma and human ovarian carcinoma to M1 activation signals was associated with a massive nuclear localization of the p50 nuclear factor-kappaB (NF-kappaB) inhibitory homodimer. p50 overexpression inhibited IL-12 expression in normal macrophages. TAM isolated from p50(-/-) mice showed normal production of M1 cytokines, associated with reduced growth of transplanted tumors. Bone marrow chimeras showed that p50 inactivation in hematopoietic cells was sufficient to result in reduced tumor growth. Thus, p50 NF-kappaB overexpression accounts for the inability of TAM to mount an effective M1 antitumor response capable of inhibiting tumor growth.


Subject(s)
Cytokines/metabolism , Macrophages/metabolism , NF-kappa B p50 Subunit/metabolism , Neoplasms/pathology , Active Transport, Cell Nucleus/drug effects , Animals , Blotting, Western , Bone Marrow Transplantation/methods , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Cells, Cultured , Cytokines/genetics , Flow Cytometry , Gene Expression/genetics , Humans , Immunohistochemistry , Inflammation/genetics , Inflammation/metabolism , Inflammation/pathology , Inflammation Mediators/immunology , Inflammation Mediators/metabolism , Interleukin-10/genetics , Interleukin-10/metabolism , Interleukin-12/genetics , Interleukin-12/metabolism , Interleukin-6/genetics , Interleukin-6/metabolism , Lipopolysaccharides/pharmacology , Macrophages/immunology , Macrophages/pathology , Mice , Mice, Knockout , NF-kappa B p50 Subunit/deficiency , NF-kappa B p50 Subunit/genetics , Neoplasms/genetics , Neoplasms/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
8.
Blood ; 107(5): 2112-22, 2006 Mar 01.
Article in English | MEDLINE | ID: mdl-16269622

ABSTRACT

To identify the molecular basis underlying the functions of tumor-associated macrophages (TAMs), we characterized the gene expression profile of TAMs isolated from a murine fibrosarcoma in comparison with peritoneal macrophages (PECs) and myeloid suppressor cells (MSCs), using a cDNA microarray technology. Among the differentially expressed genes, 15 genes relevant to inflammation and immunity were validated by real-time polymerase chain reaction (PCR) and protein production. Resting TAMs showed a characteristic gene expression pattern with higher expression of genes coding for the immunosuppressive cytokine IL-10, phagocytosis-related receptors/molecules (Msr2 and C1q), and inflammatory chemokines (CCL2 and CCL5) as expected, as well as, unexpectedly, IFN-inducible chemokines (CXCL9, CXCL10, CXCL16). Immunohistology confirmed and extended the in vitro analysis by showing that TAMs express M2-associated molecules (eg, IL-10 and MGL1), as well as CCL2, CCL5, CXCL9, CXCL10, and CXCL16, but no appreciable NOS2. Lipopolysaccharide (LPS)-mediated activation of TAMs resulted in defective expression of several proinflammatory cytokines (eg, IL-1beta, IL-6, TNF-alpha) and chemokines (eg, CCL3), as opposed to a strong up-regulation of immunosuppressive cytokines (IL-10, TGFbeta) and IFN-inducible chemokines (CCL5, CXCL9, CXCL10, CXCL16). Thus, profiling of TAMs from a murine sarcoma revealed unexpected expression of IFN-inducible chemokines, associated with an M2 phenotype (IL-10high, IL-12low), and divergent regulation of the NF-kappaB versus the IRF-3/STAT1 pathway.


Subject(s)
Fibrosarcoma/metabolism , Gene Expression Regulation, Neoplastic , Interferon Regulatory Factor-3/metabolism , Macrophages/metabolism , NF-kappa B/metabolism , STAT1 Transcription Factor/metabolism , Animals , Cell Line, Tumor , Fibrosarcoma/pathology , Gene Expression Profiling , Humans , Immunohistochemistry , Macrophages/pathology , Male , Mice , Neoplasm Transplantation , Neoplasms, Experimental/metabolism , Neoplasms, Experimental/pathology , Oligonucleotide Array Sequence Analysis , Phagocytosis , Signal Transduction
9.
Novartis Found Symp ; 256: 137-45; discussion 146-8, 259-69, 2004.
Article in English | MEDLINE | ID: mdl-15027487

ABSTRACT

Macrophages and dendritic cells infiltrate tumours. In the tumour microenvironment, mononuclear phagocytes acquire properties of polarized M2 (or alternatively activated) macrophages. These functionally polarized cells, and similarly oriented or immature dendritic cells present in tumours, play a key role in subversion of adaptive immunity and in inflammatory circuits which promote tumour growth and progression.


Subject(s)
Dendritic Cells/physiology , Macrophages/physiology , Neoplasms/immunology , Animals , Cell Movement , Humans , Macrophage Activation , Neoplasms/pathology , Phagocytes/physiology
10.
J Exp Med ; 198(9): 1391-402, 2003 Nov 03.
Article in English | MEDLINE | ID: mdl-14597738

ABSTRACT

Cell adaptation to hypoxia (Hyp) requires activation of transcriptional programs that coordinate expression of genes involved in oxygen delivery (via angiogenesis) and metabolic adaptation (via glycolysis). Here, we describe that oxygen availability is a determinant parameter in the setting of chemotactic responsiveness to stromal-derived factor 1 (CXCL12). Low oxygen concentration induces high expression of the CXCL12 receptor, CXC receptor 4 (CXCR4), in different cell types (monocytes, monocyte-derived macrophages, tumor-associated macrophages, endothelial cells, and cancer cells), which is paralleled by increased chemotactic responsiveness to its specific ligand. CXCR4 induction by Hyp is dependent on both activation of the Hyp-inducible factor 1 alpha and transcript stabilization. In a relay multistep navigation process, the Hyp-Hyp-inducible factor 1 alpha-CXCR4 pathway may regulate trafficking in and out of hypoxic tissue microenvironments.


Subject(s)
Cell Hypoxia , Phagocytes/metabolism , Receptors, CXCR4/physiology , Animals , Base Sequence , Cells, Cultured , DNA Primers , Endothelium, Vascular/cytology , Endothelium, Vascular/metabolism , Humans , Mice , RNA, Messenger/genetics , Receptors, CXCR4/genetics , Receptors, CXCR4/metabolism
11.
Blood ; 101(11): 4452-6, 2003 Jun 01.
Article in English | MEDLINE | ID: mdl-12531788

ABSTRACT

CD4, the primary receptor for entry of HIV, is known to be expressed on T cells and monocytes/macrophages; healthy natural killer (NK) lymphocytes; in vitro human herpesvirus 6 (HHV6)-infected CD8+, NK, and gammadelta T lymphocytes; CD34+ progenitor cells; and a subset of eosinophils and basophils. We here report the unconventional expression of CD4 at the surface of peripheral blood neutrophils derived from 4 of 51 (7.8%) HIV-1-infected and 3 of 25 (12%) uninfected donors, with similar frequency within the 2 groups. The percentage of CD4+ neutrophils ranged from 39% to 97% of the total neutrophil population. Both surface and cytoplasmic forms of CD4 were present in neutrophils. Quantitative RNA polymerase chain reaction (PCR) revealed that neutrophils contain levels of CD4 mRNA comparable to those of peripheral blood mononuclear cells derived from the same donor. The conformation of CD4 expressed at the surface of neutrophils was similar to that of CD4 expressed on T lymphocytes as determined by the binding of monoclonal antibodies specific for conformational epitopes and the binding of recombinant HIV-1 gp120. Thus, our data provide evidence that neutrophils express endogenous CD4 and bind HIV. Owing to their abundance in peripheral blood, CD4+ neutrophils may influence significantly the biodistribution of HIV delivering it to sites of inflammation or to additional tissue reservoirs.


Subject(s)
CD4 Antigens/analysis , HIV Infections/pathology , Neutrophils/immunology , Blood Cells , CD4 Antigens/genetics , CD4 Antigens/metabolism , Case-Control Studies , Flow Cytometry , HIV Envelope Protein gp120/metabolism , HIV Infections/immunology , Humans , Immunophenotyping , Leukocytes, Mononuclear/immunology , RNA, Messenger/analysis
12.
J Leukoc Biol ; 72(4): 780-9, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12377948

ABSTRACT

The ESb-MP T-cell line is a highly malignant murine lymphoma, which preferentially metastasizes toward the kidney. This could be a result of the local production of monocyte chemoattractant protein-1 (MCP-1) and regulated on activation, normal T expressed and secreted (RANTES), which are chemotactic for ESb-MP cells. Here, we demonstrate that ESb-MP cells are already responsive to the chemotactic activity of macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta from 1 ng/ml onward. Moreover, upon stimulation with lipopolysaccharide (LPS) or virus, ESb-MP cells themselves produce significant amounts of MIP-1 ( approximately 200 ng/ml). Indeed, the major autocrine chemoattractants, isolated from ESb-MP cells, were intact MIP-1alpha and MIP-1beta. Pretreatment with LPS or addition of MIP-1 inhibited the in vitro migration of ESb-MP cells toward various chemokines. Moreover, compared with untreated lymphoma cells, LPS-treated cells produced significantly less metastasis in mice. The results represented here suggest that the role of chemokines in attracting tumor cells at secondary sites depends on a balance between autocrine-produced and tissue-derived chemokines. This delicate balance should be considered in the design of antichemokine strategies in different tumor types.


Subject(s)
Lymphoma, T-Cell/physiopathology , Macrophage Inflammatory Proteins/physiology , Animals , Chemokine CCL3 , Chemokine CCL4 , Disease Models, Animal , Lipopolysaccharides/pharmacology , Mice , Mice, Inbred DBA , Neoplasm Metastasis , Neoplasms, Experimental , Tumor Cells, Cultured
13.
Int Immunopharmacol ; 2(8): 1045-54, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12349942

ABSTRACT

The "macrophage balance hypothesis" was proposed in the early 1990s to depict the complex relationship that tumor-associated macrophages (TAM) have with the neoplastic cells of the tumor. TAM represent a prominent component of the mononuclear leukocyte population of solid tumors, which displays an ambivalent relationship with tumors. They originate in the circulation and are recruited to the tumor site by tumor-derived attractants such as chemokines and interact with the tumor cells and preferentially localize at the tumor-host tissue interface, in regions often associated with low oxygen tensions. The tumor microenvironment, including cytokines and hypoxia, regulates the localization and function of TAM. Emerging evidence starts to define the molecular basis for the peculiar functional phenotype of TAM and identifies possible therapeutic targets.


Subject(s)
Macrophages/immunology , Neoplasms/immunology , Animals , Chemokines/genetics , Chemokines/immunology , Chemokines/metabolism , Cytokines/genetics , Cytokines/immunology , Cytokines/metabolism , Humans , Macrophages/metabolism , Neoplasms/genetics , Neoplasms/metabolism , Neovascularization, Pathologic/genetics , Neovascularization, Pathologic/immunology , Neovascularization, Pathologic/metabolism
14.
J Infect Dis ; 185(8): 1115-20, 2002 Apr 15.
Article in English | MEDLINE | ID: mdl-11930321

ABSTRACT

Neutrophils have a dual role in sepsis-defending against infection and mediating organ failure. Because glutathione (GSH) is lower in sepsis, the hypothesis that GSH depletion might impair the migratory response of neutrophils to infection was tested. In a mouse model of polymicrobial sepsis induced by cecal ligation and puncture, GSH depletion inhibited peritoneal neutrophil infiltration, increased bacterial colonies, augmented pulmonary neutrophil infiltrate, and worsened survival. The reduced peritoneal influx of neutrophils was explained by a reduced in vivo neutrophil migration in response to locally administered chemokines and by reduced chemotactic activity and chemokine levels in peritoneal lavage fluid. Conversely, the GSH precursor N-acetyl-l-cysteine augmented neutrophil infiltration in the peritoneum but not in the lung, decreased bacterial colonies, and improved survival. Thus, migration of neutrophils to a site of infection and to a distant site is differently regulated, and optimal GSH levels are important for an efficient response to sepsis.


Subject(s)
Glutathione/physiology , Inflammation/prevention & control , Neutrophils/immunology , Sepsis/prevention & control , Acetylcysteine/pharmacology , Animals , Cell Movement , Chemokines/biosynthesis , Immunity, Innate , Male , Mice , Mice, Inbred ICR , Sepsis/immunology
15.
J Biol Chem ; 277(27): 24584-93, 2002 Jul 05.
Article in English | MEDLINE | ID: mdl-11978786

ABSTRACT

Chemokines are important in leukocyte homeostasis, inflammation, angiogenesis, and metastasis. Here, the molecular diversity of chemokines present in ovarian carcinoma was studied by purifying the proteins to homogeneity from ascitic fluid. Biologically active intact CCL2 and processed CXCL8, CCL3, and CCL18 isoforms were recovered. CCL7 and CCL20 were also purified, but their levels were 10-fold lower compared with CXCL8, CCL2, and CCL3 and even 100-fold lower than the amounts of CCL18 isolated. In ascitic fluids from patients with ovarian carcinoma (n = 12), significantly higher levels of CXCL8 and CCL18 (2.0 versus 0.7 ng/ml (p = 0.01) and 120 versus 44 ng/ml (p = 0.0002), respectively) were detected compared with those in nonovarian carcinoma patients (n = 12). In contrast to CXCL8, CCL18 was not inducible in carcinoma cell lines. Immunostaining showed CCL18 expression in tumor-infiltrating cells with monocyte/macrophage morphology but not in the ovarian carcinoma cells. Our data demonstrate that biochemically heterogenous but biologically active forms of several chemokines are present at different concentrations in ovarian carcinoma ascitic fluid. This points to a delicate balance of chemokines in epithelial ovarian cancer and to a potentially major role for CXCL8 and CCL18 in this tumor.


Subject(s)
Ascites/physiopathology , Chemokines, CC/physiology , Chemokines/physiology , Ovarian Neoplasms/physiopathology , Ascites/pathology , Chemokines, CC/metabolism , Female , Humans , Immunohistochemistry , Lymphocytes, Tumor-Infiltrating/immunology , Lymphocytes, Tumor-Infiltrating/pathology , Ovarian Neoplasms/pathology , Protein Isoforms/physiology , Tumor Cells, Cultured
16.
Diabetes ; 51(1): 55-65, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11756323

ABSTRACT

We investigated the capacity of human islets to produce monocyte chemoattractant protein-1 (MCP-1). Primary cultures of pancreatic islets expressed and secreted MCP-1, as determined by Northern blot, immunohistochemistry, in situ hybridization, and enzyme-linked immunosorbent assay. The produced MCP-1 was biologically active as it attracted monocytes in chemotaxis assay, and chemotactic activity was almost abrogated by a neutralizing anti-MCP-1 monoclonal antibody. Expression of MCP-1 was increased by primary inflammatory cytokines (interleukin-1 beta, tumor necrosis factor-alpha) and lipopolysaccharide at both the mRNA and protein levels but not by glucose. However, MCP-1 did not modulate insulin secretion. MCP-1 secreted by pancreatic islets plays a relevant role in the clinical outcome of islet transplant in patients with type 1 diabetes. In fact, low MCP-1 secretion resulted as the most relevant factor for long-lasting insulin independence. This finding opens new approaches in the management of human islet transplantation. Finally, the finding that MCP-1 appears constitutively present in normal human islet beta-cells (immunohistochemistry and in situ hybridization), in the absence of an inflammatory infiltrate, suggests that this chemokine could have functions other than monocyte recruitment and opens a new link between the endocrine and immune systems.


Subject(s)
Chemokine CCL2/genetics , Diabetes Mellitus, Type 1/surgery , Insulin/metabolism , Islets of Langerhans Transplantation/physiology , Islets of Langerhans/metabolism , Adult , Blotting, Northern , Cells, Cultured , Chemokine CCL2/metabolism , Chemokine CCL2/pharmacology , Chemotaxis, Leukocyte/drug effects , Cytokines/pharmacology , Diabetic Nephropathies/surgery , Enzyme-Linked Immunosorbent Assay , Female , Gene Expression Regulation , Humans , Immunosuppression Therapy , Insulin Secretion , Kidney Transplantation , Male , Middle Aged , Monocytes/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...